LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for early lung cancer
Disease control OngoingThis study tests whether adding an immunotherapy drug (nivolumab) to precise, high-dose radiation therapy helps prevent lung cancer from coming back in people with early-stage non-small cell lung cancer. About 140 participants will receive either radiation alone or radiation plus…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill shows promise for Hard-to-Treat neuroendocrine tumors
Disease control OngoingThis phase II trial is testing an oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The drug aims to slow tumor growth and improve disease control. Participants take the pill twice daily, with a possible dos…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Massive study aims to unravel best treatments for neuroendocrine tumors
Knowledge-focused OngoingThis study follows over 2,500 people with neuroendocrine tumors (NETs) to understand their symptoms and how treatments are chosen. Participants fill out surveys about quality of life and care experiences over 18 months. Researchers will link this to medical records to find which …
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC